{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:39:57Z","timestamp":1761946797326,"version":"build-2065373602"},"reference-count":34,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T00:00:00Z","timestamp":1492732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Diabetes UK RD Lawrence Fellowship","award":["13\/0004647 to C. B"],"award-info":[{"award-number":["13\/0004647 to C. B"]}]},{"DOI":"10.13039\/100014669","name":"British Society for Neuroendocrinology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014669","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000382","name":"Society for Endocrinology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000382","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Mary Kinross Charitable Trust"},{"name":"Tenovus Scotland"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>\n                      To test the hypothesis that, given the role of\n                      <jats:styled-content style=\"fixed-case\">AMP<\/jats:styled-content>\n                      \u2010activated protein kinase (\n                      <jats:styled-content style=\"fixed-case\">AMPK<\/jats:styled-content>\n                      ) in regulating intracellular\n                      <jats:styled-content style=\"fixed-case\">ATP<\/jats:styled-content>\n                      levels,\n                      <jats:styled-content style=\"fixed-case\">AMPK<\/jats:styled-content>\n                      may alter\n                      <jats:styled-content style=\"fixed-case\">ATP<\/jats:styled-content>\n                      release from astrocytes, the main sources of extracellular\n                      <jats:styled-content style=\"fixed-case\">ATP<\/jats:styled-content>\n                      (\n                      <jats:styled-content style=\"fixed-case\">eATP<\/jats:styled-content>\n                      ) within the brain.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>\n                      Measurements of\n                      <jats:styled-content style=\"fixed-case\">ATP<\/jats:styled-content>\n                      release were made from human\n                      <jats:styled-content style=\"fixed-case\">U373<\/jats:styled-content>\n                      astrocytoma cells, primary mouse hypothalamic (\n                      <jats:styled-content style=\"fixed-case\">HTAS<\/jats:styled-content>\n                      ) and cortical astrocytes (\n                      <jats:styled-content style=\"fixed-case\">CRTAS<\/jats:styled-content>\n                      ) and wild\u2010type and\n                      <jats:styled-content style=\"fixed-case\">AMPK<\/jats:styled-content>\n                      \u03b11\/\u03b12 null mouse embryonic fibroblasts (\n                      <jats:styled-content style=\"fixed-case\">MEFs<\/jats:styled-content>\n                      ). Cells were treated with drugs known to modulate\n                      <jats:styled-content style=\"fixed-case\">AMPK<\/jats:styled-content>\n                      activity:\n                      <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>\n                      \u2010769662,\n                      <jats:styled-content style=\"fixed-case\">AICAR<\/jats:styled-content>\n                      and metformin, for up to 3\u2009hours. Intracellular calcium was measured using\n                      <jats:styled-content style=\"fixed-case\">F<\/jats:styled-content>\n                      luo4 and\n                      <jats:styled-content style=\"fixed-case\">F<\/jats:styled-content>\n                      ura\u20102 calcium\u2010sensitive fluorescent dyes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In\n                      <jats:styled-content style=\"fixed-case\">U373<\/jats:styled-content>\n                      cells,\n                      <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>\n                      \u2010769662 (100\u2009\u03bcM) increased\n                      <jats:styled-content style=\"fixed-case\">AMPK<\/jats:styled-content>\n                      phosphorylation, whereas\n                      <jats:styled-content style=\"fixed-case\">AICAR<\/jats:styled-content>\n                      and metformin (1\u2009mM) induced a modest increase or had no effect, respectively. Only\n                      <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>\n                      \u2010769662 increased\n                      <jats:styled-content style=\"fixed-case\">eATP<\/jats:styled-content>\n                      levels, and this was partially blocked by\n                      <jats:styled-content style=\"fixed-case\">AMPK<\/jats:styled-content>\n                      inhibitor\n                      <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>\n                      ompound\n                      <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>\n                      . A\u2010769662\u2010induced increases in\n                      <jats:styled-content style=\"fixed-case\">eATP<\/jats:styled-content>\n                      were preserved in\n                      <jats:styled-content style=\"fixed-case\">AMPK<\/jats:styled-content>\n                      \u03b11\/\u03b12 null\n                      <jats:styled-content style=\"fixed-case\">MEF<\/jats:styled-content>\n                      cells. A\u2010769662 increased intracellular calcium in\n                      <jats:styled-content style=\"fixed-case\">U373<\/jats:styled-content>\n                      ,\n                      <jats:styled-content style=\"fixed-case\">HTAS<\/jats:styled-content>\n                      and\n                      <jats:styled-content style=\"fixed-case\">CRTAS<\/jats:styled-content>\n                      cells and chelation of intracellular calcium using\n                      <jats:styled-content style=\"fixed-case\">BAPTA\u2010AM<\/jats:styled-content>\n                      reduced\n                      <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>\n                      \u2010769662\u2010induced\n                      <jats:styled-content style=\"fixed-case\">eATP<\/jats:styled-content>\n                      levels. A\u2010769662 also increased\n                      <jats:styled-content style=\"fixed-case\">ATP<\/jats:styled-content>\n                      release from a number of other central and peripheral endocrine cell types.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      <jats:styled-content style=\"fixed-case\">AMPK<\/jats:styled-content>\n                      is required to maintain basal\n                      <jats:styled-content style=\"fixed-case\">eATP<\/jats:styled-content>\n                      levels but is not required for\n                      <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>\n                      \u2010769662\u2010induced increases in\n                      <jats:styled-content style=\"fixed-case\">eATP<\/jats:styled-content>\n                      . A\u2010769662 (&gt;50\u2009\u03bcM) enhanced intracellular calcium levels leading to\n                      <jats:styled-content style=\"fixed-case\">ATP<\/jats:styled-content>\n                      release in an\n                      <jats:styled-content style=\"fixed-case\">AMPK<\/jats:styled-content>\n                      and purinergic receptor independent pathway.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dom.12912","type":"journal-article","created":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T07:02:50Z","timestamp":1487314970000},"page":"997-1005","source":"Crossref","is-referenced-by-count":23,"title":["<scp>AMP<\/scp>\n                    \u2010activated protein kinase (\n                    <scp>AMPK<\/scp>\n                    ) activator\n                    <scp>A<\/scp>\n                    \u2010769662 increases intracellular calcium and\n                    <scp>ATP<\/scp>\n                    release from astrocytes in an\n                    <scp>AMPK<\/scp>\n                    \u2010independent manner"],"prefix":"10.1111","volume":"19","author":[{"given":"Julia M.","family":"Vlachaki Walker","sequence":"first","affiliation":[{"name":"Institute of Biomedical and Clinical Sciences University of Exeter Medical School  Exeter UK"},{"name":"Division of Molecular and Clinical Medicine Ninewells Hospital and Medical School, University of Dundee  Dundee UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josephine L.","family":"Robb","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Sciences University of Exeter Medical School  Exeter UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana M.","family":"Cruz","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Sciences University of Exeter Medical School  Exeter UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amrinder","family":"Malhi","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Sciences University of Exeter Medical School  Exeter UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul G.","family":"Weightman Potter","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Sciences University of Exeter Medical School  Exeter UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael L. J.","family":"Ashford","sequence":"additional","affiliation":[{"name":"Division of Molecular and Clinical Medicine Ninewells Hospital and Medical School, University of Dundee  Dundee UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rory J.","family":"McCrimmon","sequence":"additional","affiliation":[{"name":"Division of Molecular and Clinical Medicine Ninewells Hospital and Medical School, University of Dundee  Dundee UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate L. J.","family":"Ellacott","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Sciences University of Exeter Medical School  Exeter UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4263-0866","authenticated-orcid":false,"given":"Craig","family":"Beall","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Sciences University of Exeter Medical School  Exeter UK"},{"name":"Division of Molecular and Clinical Medicine Ninewells Hospital and Medical School, University of Dundee  Dundee UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,4,21]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1042\/CS20160048"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(87)80292-2"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(03)00929-2"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1997.273.6.E1107"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature02440"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C300557200"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.2337\/db07-0837"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11302-012-9300-0"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.139.7.1635"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1004282107"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI59660"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/cne.23233"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/oby.21248"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2014.10.001"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3579-15.2016"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.07.028"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3725"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.04.002"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.07.043"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0031-9384(93)90141-2"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2005.12.021"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0361-9230(88)90159-1"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/glia.10124"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2012.12.001"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M209454200"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2008.10.005"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.034140"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2012.09.024"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1190721"},{"key":"e_1_2_6_31_1","first-page":"1","article-title":"Purinergic signalling in the rostral ventro\u2010lateral medulla controls sympathetic drive and contributes to the progression of heart failure following myocardial infarction in rats","volume":"108","author":"Marina N","year":"2012","journal-title":"Basic Res Cardiol"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.2337\/db12-1066"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2010.10.028"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.8.4615"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11302-015-9474-3"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdom.12912","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/dom.12912","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T21:45:50Z","timestamp":1761860750000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/10.1111\/dom.12912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,21]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["10.1111\/dom.12912"],"URL":"https:\/\/doi.org\/10.1111\/dom.12912","archive":["Portico"],"relation":{},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"type":"print","value":"1462-8902"},{"type":"electronic","value":"1463-1326"}],"subject":[],"published":{"date-parts":[[2017,4,21]]}}}